Mettler-Toledo International Inc. (NYSE:MTD) Shares Acquired by Achmea Investment Management B.V.

Achmea Investment Management B.V. boosted its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 1.7% in the 4th quarter, Holdings Channel reports. The firm owned 33,371 shares of the medical instruments supplier’s stock after buying an additional 573 shares during the period. Mettler-Toledo International makes up approximately 0.7% of Achmea Investment Management B.V.’s portfolio, making the stock its 28th largest holding. Achmea Investment Management B.V.’s holdings in Mettler-Toledo International were worth $40,835,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. State Street Corp lifted its position in shares of Mettler-Toledo International by 1.0% in the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after acquiring an additional 9,009 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Mettler-Toledo International by 0.8% in the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after acquiring an additional 4,166 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of Mettler-Toledo International by 13.9% in the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after acquiring an additional 33,456 shares in the last quarter. Barclays PLC lifted its position in shares of Mettler-Toledo International by 8.3% in the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after acquiring an additional 19,609 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after acquiring an additional 28,478 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Trading Down 2.1 %

Mettler-Toledo International stock opened at $1,216.92 on Thursday. The company has a market capitalization of $25.45 billion, a P/E ratio of 30.03, a P/E/G ratio of 3.30 and a beta of 1.15. The firm’s fifty day simple moving average is $1,295.55 and its 200-day simple moving average is $1,320.34. Mettler-Toledo International Inc. has a 1-year low of $1,142.91 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. On average, equities research analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Insider Activity

In related news, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the transaction, the insider now owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the transaction, the insider now owns 6 shares in the company, valued at $8,108.04. This trade represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by insiders.

Wall Street Analyst Weigh In

MTD has been the subject of several research analyst reports. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Robert W. Baird upped their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. Finally, Citigroup dropped their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and a consensus price target of $1,380.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.